Advaxis’ ‘Prokaryotic peptides for enhancing antigen immunogenicity’ European patent application allowed
Advaxis’ ‘Prokaryotic peptides for enhancing antigen immunogenicity’ European patent application allowed
Advaxis, Inc.,, the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has been notified by the European Patent Office that patent application WO2001/072329, for the use of Prokaryotic PEST-Like Peptides for Enhancing Immunogenicity of Antigen has been allowed for issuance. This patent will be #1,303,299 when granted, and will be licensed exclusively to Advaxis by the University …
Read more on News-Medical-Net
Categories: Breast Cancer Tumor Tags: 'Prokaryotic, Advaxis, allowed, antigen, application, enhancing, European, immunogenicity', Patent, peptides